1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 437 F.Supp.3d
  5. 437 F.Supp.3d 1381 (2020)
 

IN RE PREVAGEN PRODUCTS MARKETING

MDL No. 2929.

437 F.Supp.3d 1381 (2020)

IN RE: PREVAGEN PRODUCTS MARKETING and Sales Practices Litigation (No. II).

United States Judicial Panel on Multidistrict Litigation.

March 30, 2020.

ORDER DENYING TRANSFER

Before the Panel:* Defendants Quincy Bioscience Holding Company, Inc., Quincy Bioscience, LLC, Prevagen, Inc., Quincy Bioscience Manufacturing, LLC, Mark Underwood, and Michael Beaman (collectively Quincy Defendants) move under 28 U.S.C...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases